Search results
Peak Private Credit Fears Force Funds to Scrabble for Returns
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- In an effort to sustain the stellar returns of recent years, private credit funds are...
Dev Log April - May 2024: Militia Finale (Finally) Complete! news - Prometheus Wept
Indie DB· 3 days agoYou can wishlist Prometheus Wept, on Steam, here. Olga has been working on illustrations for key...
Advent Nears Deal for Prometheus Software Firm Stake
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Buyout firm Advent International is nearing a deal to acquire a stake in Prometheus Group in a transaction that could value the industrial...
Is Your Blockchain Invention Patentable?
The National Law Review· 2 hours agoBlockchain is becoming central to more FinTech patent portfolios than ever – but it’s harder to obtain protection on blockchain than most other...
A QA Engineer Is Like Prometheus (And Why That's a Good Thing)
MediaPost· 7 days agoIn Greek mythology, Prometheus defied the gods by stealing fire from Mount Olympus and giving it to humanity. Having spent over a decade in software development, I relate ...
The DCU's Green Lanterns Max series has found its chief creative team, and one particular addition...
TechRadar· 2 days agoThe most recognizable name among that contingent is Damon Lindelof, who co-created hit early 2000s...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 1 day ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Obscure Sci-Fi Movie ‘Upgrade’ Surges On Netflix Global Top 10 Chart
Forbes· 6 days agoUpgrade—an obscure sci-fi tech thriller from 2018—has gotten a power boost from Netflix viewers. The...
The oldest tree in the world: Meet 'Methuselah,' a literal hidden gem.
USA Today· 3 days agoTrees that have stood tall through extreme weather, pests, diseases and human interactions, for...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 1 day agoKeytruda made up more than 40% of Merck’s $60 billion in sales last year. Among Davis’s deals were...
